Corcept director granted 12,500 stock options
Corcept Therapeutics director Daniel N. Swisher Jr. received a grant of 12,500 stock options for common stock on May 21, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Corcept Therapeutics director Daniel N. Swisher Jr. received a grant of 12,500 stock options for common stock on May 21, 2026. The options have an exercise price of $59.69 per share and expire on May 21, 2036. They vest in equal monthly installments over one year starting May 21, 2026, conditioned on his continued service.
Insider Trade Summary
Grant/Award: 12,500 shares
Grant/Award
1 txn
Insider
Swisher Daniel N JR
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 12,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 12,500 contracts (Direct)
Footnotes (1)
- F1. Exercisable ratably in equal installments on each monthly anniversary of May 21, 2026 over a one-year period, subject to the Reporting Person's continued service on each monthly vesting date.
Key Figures
Stock options granted: 12,500 options
Exercise price: $59.69 per share
Underlying shares: 12,500 shares
+3 more
6 metrics
Stock options granted
12,500 options
Grant to director on May 21, 2026
Exercise price
$59.69 per share
Stock option exercise price
Underlying shares
12,500 shares
Common stock underlying the options
Expiration date
May 21, 2036
Option term end date
Vesting schedule
Monthly over one year
From May 21, 2026, subject to continued service
Options held after grant
12,500 options
Total derivative holdings following transaction
Key Terms
Stock Option (right to buy), exercise price, expiration date, underlying security, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 59.6900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-05-21T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title: Common Stock"
vesting financial
"Exercisable ratably in equal installments on each monthly anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Daniel N. Swisher Jr. acquire in the latest CORT Form 4 filing?
Daniel N. Swisher Jr. received a grant of 12,500 stock options for Corcept Therapeutics common stock. These options represent compensation rather than an open-market purchase, giving him the right to buy shares at a fixed exercise price in the future.
What is the exercise price of the new Corcept (CORT) stock options?
The granted stock options carry an exercise price of $59.69 per share. This means Swisher can choose to buy Corcept common stock at $59.69, regardless of the market price, once the options are vested and before they expire.
When do Daniel Swisher’s Corcept stock options vest and over what period?
The options vest ratably in equal installments on each monthly anniversary of May 21, 2026 over a one-year period. Vesting is conditioned on Swisher’s continued service with Corcept on each monthly vesting date, tying the award to ongoing tenure.
When do the newly granted Corcept (CORT) stock options expire?
The stock options granted to Daniel N. Swisher Jr. expire on May 21, 2036. He must exercise any vested options before that expiration date; otherwise, the right to purchase shares at the fixed exercise price lapses.
How many Corcept stock options does Daniel Swisher hold after this grant?
Following this transaction, Swisher holds 12,500 stock options directly. These options are linked to an equal number of underlying Corcept common shares, providing potential future ownership if he chooses to exercise the award.
AI-generated analysis. How Rhea-AI works. Not financial advice.
